Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PPH vs FPHAX overlap: 41% of top holdings shared

Bottom line

How much do PPH and FPHAX overlap?

41% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 46.5% of PPH's assets and 64.4% of FPHAX's. They share a meaningful core but differ in the rest of the portfolio.

FPHAX holds far more positions (57 vs 26), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PPHFPHAX
Weight overlap (top 25)41%
Shared holdings9
Weight in shared holdings46.5%64.4%
Total positions2657
Expense ratio0.36%0.67%
Holdings as ofJun 30, 2026May 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Holdings PPH and FPHAX have in common

Holding% of PPH% of FPHAXOverlap
Eli Lilly & Co20.23%28.78%20.23%
Merck & Co Inc9.85%4.74%4.74%
Gsk Plc4.42%8.17%4.42%
Johnson & Johnson4.35%3.77%3.77%
AstraZeneca PLC4.33%4.22%4.22%
Viatris Inc1.10%5.45%1.10%
Jazz Pharmaceuticals PLC1.08%4.09%1.08%
Axsome Therapeutics Inc0.77%1.08%0.77%
Elanco Animal Health Inc0.35%4.15%0.35%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PPH

  1. Novartis AG — 10.63%
  2. Novo Nordisk A/S — 5.37%
  3. AbbVie Inc — 4.57%
  4. Pfizer Inc — 4.51%
  5. Bristol-Myers Squibb Co — 4.47%
  6. McKesson Corp — 4.12%
  7. Sanofi SA — 4.00%
  8. Cencora Inc — 3.36%
  9. Haleon PLC — 3.09%
  10. Teva Pharmaceutical Industries Ltd — 3.06%
  11. Takeda Pharmaceutical Co Ltd — 2.87%
  12. Zoetis Inc — 2.10%
  13. Corcept Therapeutics Inc — 0.50%
  14. State Street Global Advisors — 0.28%
  15. Organon & Co — 0.23%

Only in FPHAX

  1. Ucb Sa — 5.09%
  2. Roche Holding Ag — 4.54%
  3. Legend Biotech Corp — 4.53%
  4. Gilead Sciences Inc — 3.97%
  5. Royalty Pharma Plc — 2.67%
  6. Fidelity Revere Street Trust — 2.44%
  7. Moderna Inc — 1.57%
  8. Intellia Therapeutics Inc — 1.19%
  9. Beam Therapeutics Inc — 1.10%
  10. Biontech Se — 1.04%
  11. Xenon Pharmaceuticals Inc — 0.82%
  12. Ocular Therapeutix Inc — 0.80%
  13. Idexx Laboratories Inc — 0.61%
  14. Swedish Orphan Biovitrum Ab — 0.54%
  15. Ptc Therapeutics Inc — 0.54%

Asset mix

Asset typePPHFPHAX
Stocks99.5%98.7%
Cash & short-term funds0.3%2.6%
Preferred stock—0.7%
Bonds—0.1%

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Country mix

CountryPPHFPHAX
US60.8%64.8%
GB11.8%15.1%
CH10.6%4.5%
DK5.4%0.3%
BE—5.3%
KY—4.5%
IE1.1%4.1%
FR4.0%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)

Check another pair

FAQ

How much do PPH and FPHAX overlap?
About 41% by weight. 9 securities appear in both funds' top 25 holdings; they make up 46.5% of PPH's assets and 64.4% of FPHAX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PPH and FPHAX have in common?
The largest shared holdings are Eli Lilly & Co, Merck & Co Inc, Gsk Plc, AstraZeneca PLC, Johnson & Johnson.
Should I own both PPH and FPHAX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PPH or FPHAX?
FPHAX is broader, with 57 positions versus 26 for PPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.